1. Computational and Systems Biology
  2. Microbiology and Infectious Disease
Download icon

Incomplete inhibition of HIV infection results in more HIV infected lymph node cells by reducing cell death

  1. Laurelle Jackson
  2. Jessica Hunter
  3. Sandile Cele
  4. Isabella Markham Ferreira
  5. Andrew C Young
  6. Farina Karim
  7. Rajhmun Madansein
  8. Kaylesh J Dullabh
  9. Chih-Yuan Chen
  10. Noel J Buckels
  11. Yashica Ganga
  12. Khadija Khan
  13. Mikael Boulle
  14. Gila Lustig
  15. Richard A Neher
  16. Alex Sigal  Is a corresponding author
  1. Africa Health Research Institute, South Africa
  2. University of KwaZulu-Natal, South Africa
  3. University of Basel, Switzerland
Research Article
  • Cited 1
  • Views 1,393
  • Annotations
Cite this article as: eLife 2018;7:e30134 doi: 10.7554/eLife.30134

Abstract

HIV has been reported to be cytotoxic in vitro and in lymph node infection models. Using a computational approach, we found that partial inhibition of transmissions of multiple virions per cell could lead to increased numbers of live infected cells. If the number of viral DNA copies remains above one after inhibition, then eliminating the surplus viral copies reduces cell death. Using a cell line, we observed increased numbers of live infected cells when infection was partially inhibited with the antiretroviral efavirenz or neutralizing antibody. We then used efavirenz at concentrations reported in lymph nodes to inhibit lymph node infection by partially resistant HIV mutants. We observed more live infected lymph node cells, but with fewer HIV DNA copies per cell, relative to no drug. Hence, counterintuitively, limited attenuation of HIV transmission per cell may increase live infected cell numbers in environments where the force of infection is high.

Article and author information

Author details

  1. Laurelle Jackson

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  2. Jessica Hunter

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  3. Sandile Cele

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  4. Isabella Markham Ferreira

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  5. Andrew C Young

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3616-7956
  6. Farina Karim

    Division of Clinical Studies, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  7. Rajhmun Madansein

    Department of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa
    Competing interests
    No competing interests declared.
  8. Kaylesh J Dullabh

    Department of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa
    Competing interests
    No competing interests declared.
  9. Chih-Yuan Chen

    Department of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa
    Competing interests
    No competing interests declared.
  10. Noel J Buckels

    Department of Cardiothoracic Surgery, University of KwaZulu-Natal, Durban, South Africa
    Competing interests
    No competing interests declared.
  11. Yashica Ganga

    Division of Clinical Studies, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  12. Khadija Khan

    Division of Clinical Studies, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  13. Mikael Boulle

    Division of Clinical Studies, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  14. Gila Lustig

    Division of Clinical Studies, Africa Health Research Institute, Durban, South Africa
    Competing interests
    No competing interests declared.
  15. Richard A Neher

    Biozentrum, University of Basel, Basel, Switzerland
    Competing interests
    Richard A Neher, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2525-1407
  16. Alex Sigal

    Systems Infection Biology, Africa Health Research Institute, Durban, South Africa
    For correspondence
    alex.sigal@k-rith.org
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8571-2004

Funding

Human Frontier Science Program (CDA 00050/2013)

  • Alex Sigal

European Research Council (Stg. 260686)

  • Richard A Neher

DELTAS Africa Initiative (Graduate Fellowship)

  • Isabella Markham Ferreira

National Research Foundation (Graduate Fellowship)

  • Laurelle Jackson

National Institutes of Health (R21MH104220)

  • Alex Sigal

National Research Foundation (Graduate Fellowship)

  • Jessica Hunter

Poliomyelitis Research Foundation (Graduate Fellowship)

  • Isabella Markham Ferreira

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Lymph nodes were obtained from the field of surgery of participants undergoing surgery for diagnostic purposes and/or complications of inflammatory lung disease. Informed consent was obtained from each participant, and the study protocol approved by the University of KwaZulu-Natal Institutional Review Board (approval BE024/09).

Reviewing Editor

  1. Wenying Shou, Fred Hutchinson Cancer Research Center, United States

Publication history

  1. Received: July 18, 2017
  2. Accepted: March 8, 2018
  3. Accepted Manuscript published: March 20, 2018 (version 1)
  4. Version of Record published: April 10, 2018 (version 2)

Copyright

© 2018, Jackson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,393
    Page views
  • 181
    Downloads
  • 1
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Computational and Systems Biology
    2. Immunology and Inflammation
    George Ueda et al.
    Research Article

    Multivalent presentation of viral glycoproteins can substantially increase the elicitation of antigen-specific antibodies. To enable a new generation of anti-viral vaccines, we designed self-assembling protein nanoparticles with geometries tailored to present the ectodomains of influenza, HIV, and RSV viral glycoprotein trimers. We first de novo designed trimers tailored for antigen fusion, featuring N-terminal helices positioned to match the C termini of the viral glycoproteins. Trimers that experimentally adopted their designed configurations were incorporated as components of tetrahedral, octahedral, and icosahedral nanoparticles, which were characterized by cryo-electron microscopy and assessed for their ability to present viral glycoproteins. Electron microscopy and antibody binding experiments demonstrated that the designed nanoparticles presented antigenically intact prefusion HIV-1 Env, influenza hemagglutinin, and RSV F trimers in the predicted geometries. This work demonstrates that antigen-displaying protein nanoparticles can be designed from scratch, and provides a systematic way to investigate the influence of antigen presentation geometry on the immune response to vaccination.

    1. Computational and Systems Biology
    2. Developmental Biology
    Bjoern Gaertner et al.
    Research Article

    Long noncoding RNAs (lncRNAs) are a heterogenous group of RNAs, which can encode small proteins. The extent to which developmentally regulated lncRNAs are translated and whether the produced microproteins are relevant for human development is unknown. Using a human embryonic stem cell (hESC)-based pancreatic differentiation system, we show that many lncRNAs in direct vicinity of lineage-determining transcription factors (TFs) are dynamically regulated, predominantly cytosolic, and highly translated. We genetically ablated ten such lncRNAs, most of them translated, and found that nine are dispensable for pancreatic endocrine cell development. However, deletion of LINC00261 diminishes insulin+ cells, in a manner independent of the nearby TF FOXA2. One-by-one deletion of each of LINC00261's open reading frames suggests that the RNA, rather than the produced microproteins, is required for endocrine development. Our work highlights extensive translation of lncRNAs during hESC pancreatic differentiation and provides a blueprint for dissection of their coding and noncoding roles.